MedWatch

Danish Medicines Agency considers reporting Europharma DK again

Already once this year, the Danish Medicines Agency reported the parallel importer Europharma DK to the police. Now, the agency considers reporting the company again after a new suspension of Europharma’s authorization for secondary repackaging and release of medicinal products.

Photo: Colourbox

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

FDA vil lette vejen til markedet for medicin mod Alzheimers

De amerikanske lægemiddelmyndigheder vil lempe kravene til godkendelse af lægemidler mod Alzheimers, fordi forskning viser, at sygdommen indtræder tidligere end hidtil antaget. Lægemiddeludviklingen og godkendelse heraf derfor skal tilpasses derefter, mener FDA-boss Scott Gottlieb.

Related articles